InvestorsHub Logo
Followers 53
Posts 4314
Boards Moderated 0
Alias Born 02/28/2010

Re: None

Tuesday, 01/08/2013 5:05:46 PM

Tuesday, January 08, 2013 5:05:46 PM

Post# of 130513
The presentation was a major disappointment. They showed data from four different studies and came up with the conclusion that MANF demonstrated "potential benefit" over GDNF.

Dr. Rubinfeld barely had to time to note that he was formerly with Amgen back in the day. Didn't add anything worthwhile.

See you at .05 tomorrow.

p.s. I told you to sell some shares today.